Literature DB >> 11700579

Laboratory diagnostic techniques for patients with early Lyme disease associated with erythema migrans: a comparison of different techniques.

J Nowakowski1, I Schwartz, D Liveris, G Wang, M E Aguero-Rosenfeld, G Girao, D McKenna, R B Nadelman, L F Cavaliere, G P Wormser.   

Abstract

Recently, a number of refinements in diagnostic modalities for detection of Borrelia burgdorferi infection have been developed. These include large-volume blood cultures, quantitative polymerase chain reaction (PCR) techniques, and 2-stage serologic testing. In the present study, we compared 6 diagnostic modalities in 47 adult patients who had a clinical diagnosis of erythema migrans. Quantitative PCR on skin biopsy-derived material was the most sensitive diagnostic method (80.9%), followed by 2-stage serologic testing of convalescent-phase samples (66.0%), conventional nested PCR (63.8%), skin culture (51.1%), blood culture (44.7%), and serologic testing of acute-phase samples (40.4%). Results of all assays were negative for 3 patients (6.4%). We conclude that the clinical diagnosis of erythema migrans is highly accurate in an area where B. burgdorferi is endemic if it is made by experienced health care personnel, but some patients with this diagnosis may not have B. burgdorferi infection. No single diagnostic modality is suitable for detection of B. burgdorferi in every patient with erythema migrans.

Entities:  

Mesh:

Year:  2001        PMID: 11700579     DOI: 10.1086/324490

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  49 in total

1.  Two-year evaluation of Borrelia burgdorferi culture and supplemental tests for definitive diagnosis of Lyme disease.

Authors:  Peggy Coulter; Clara Lema; Diane Flayhart; Amy S Linhardt; John N Aucott; Paul G Auwaerter; J Stephen Dumler
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

2.  Comparison of immunofluorescence assay (IFA) and LIAISON in patients with different clinical manifestations of Lyme borreliosis.

Authors:  Tjasa Cerar; Eva Ruzic-Sabljic; Joze Cimperman; Franc Strle
Journal:  Wien Klin Wochenschr       Date:  2006-11       Impact factor: 1.704

Review 3.  The emergence of Lyme disease in Canada.

Authors:  Nicholas H Ogden; L Robbin Lindsay; Muhammad Morshed; Paul N Sockett; Harvey Artsob
Journal:  CMAJ       Date:  2009-06-09       Impact factor: 8.262

4.  Erythema migrans in Lyme disease.

Authors:  David A Wetter; Colin A Ruff
Journal:  CMAJ       Date:  2011-05-30       Impact factor: 8.262

5.  Collection and characterization of samples for establishment of a serum repository for lyme disease diagnostic test development and evaluation.

Authors:  Claudia R Molins; Christopher Sexton; John W Young; Laura V Ashton; Ryan Pappert; Charles B Beard; Martin E Schriefer
Journal:  J Clin Microbiol       Date:  2014-08-13       Impact factor: 5.948

6.  Decorin binding proteins A and B in the serodiagnosis of Lyme disease in North America.

Authors:  Paul M Arnaboldi; Mariya Sambir; Raymond J Dattwyler
Journal:  Clin Vaccine Immunol       Date:  2014-08-13

7.  Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease.

Authors:  Gary P Wormser; Martin Schriefer; Maria E Aguero-Rosenfeld; Andrew Levin; Allen C Steere; Robert B Nadelman; John Nowakowski; Adriana Marques; Barbara J B Johnson; J Stephen Dumler
Journal:  Diagn Microbiol Infect Dis       Date:  2012-10-11       Impact factor: 2.803

8.  Differentiation of reinfection from relapse in recurrent Lyme disease.

Authors:  Robert B Nadelman; Klára Hanincová; Priyanka Mukherjee; Dionysios Liveris; John Nowakowski; Donna McKenna; Dustin Brisson; Denise Cooper; Susan Bittker; Gul Madison; Diane Holmgren; Ira Schwartz; Gary P Wormser
Journal:  N Engl J Med       Date:  2012-11-15       Impact factor: 91.245

9.  Quantitative analysis of Borrelia burgdorferi gene expression in naturally (tick) infected mouse strains.

Authors:  Sharon Lederer; Christiane Brenner; Thomas Stehle; Lise Gern; Reinhard Wallich; Markus M Simon
Journal:  Med Microbiol Immunol       Date:  2005-01       Impact factor: 3.402

10.  Borrelia burgdorferi genotype predicts the capacity for hematogenous dissemination during early Lyme disease.

Authors:  Gary P Wormser; Dustin Brisson; Dionysios Liveris; Klára Hanincová; Sabina Sandigursky; John Nowakowski; Robert B Nadelman; Sara Ludin; Ira Schwartz
Journal:  J Infect Dis       Date:  2008-11-01       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.